John Foglesong

John Foglesong (co-founder, president and CEO) brings more than 20 years of biotech and pharma experiences in both large pharma and small biotech organizations. His experience is truly multidisciplinary with expertise in manufacturing, portfolio management, strategic consulting, sales and marketing, commercial operations, and new product planning. Prior to his current role, he was responsible for the commercialization/scale-up of the allogeneic T-cell therapy matching platform and processes for Atara BioTherapeutics. Prior to this he spent nearly 10 years at Genentech, holding roles across strategic planning / portfolio management, sales and marketing, and commercial operations. While at Genentech he worked in oncology, neurosciences, and endocrinology, and participated in multiple product launches and line extensions. He has also spent time as a management consultant as part of the life sciences practice of Oliver Wyman, as well as in dry products fill/finish manufacturing and qu